HONEYWELL INTERNATIONAL INC., Petitioner, v. ENVIRONMENTAL PROTECTION AGENCY, Respondent. ATOFINA Chemicals, Inc., Intervenor.
No. 02-1294.
United States Court of Appeals, District of Columbia Circuit.
Argued Feb. 26, 2004. Decided July 23, 2004.
374 F.3d 1363
Thomas A. Lorenzen, Attorney, U.S. Department of Justice, argued the cause for respondent. With him on the brief were Steven Edward Rusak, Attorney, Lisa M. Jaeger, Acting General Counsel, U.S. Environmental Protection Agency, and Jan M. Tierney, Attorney.
Sheila A. Millar argued the cause for intervenor ATOFINA Chemicals, Inc. With her on the brief were Peter L. de la Cruz and Jean-Cyril Walker.
Before: SENTELLE, RANDOLPH and ROGERS, Circuit Judges.
Opinion for the Court filed PER CURIAM.
Opinion concurring in part and dissenting in part filed by Circuit Judge ROGERS.
PER CURIAM:
The opinion of the court is presented in two parts. In the first part, Judge Rogers writes for a unanimous court to introduce the issues presented and to hold that Honeywell International Inc. has standing to challenge the rule on review promulgated by the Environmental Protection Agency (“EPA“). In the second part, Judge Sentelle writes for himself and Judge Randolph on Honeywell‘s challenge to EPA‘s reliance on economic considerations in promulgating the rule on review, concluding that the rule must be vacated; Judge Randolph writes on the remedy; and Judge Rogers concurs in part and dissents in part, and would remand the rule to EPA for further explanation.
PART I
ROGERS, Circuit Judge, writing in PART I the opinion of the court:
Title VI of the Clean Air Act (“CAA“),
I.
Title VI of the Clean Air Act,
As relevant to Honeywell‘s petition for review, the Administrator must also “promulgate rules providing that it shall be unlawful to replace any class I or class II substance with any substitute substance which the Administrator determines may present adverse effects to human health or the environment, where the Administrator has identified an alternative to such replacement that—(1) reduces the overall risk to human health and the environment; and (2) is currently or potentially available.”
In 1993, EPA, acting pursuant to
The final rule followed upon intervenor ATOFINA Chemicals, Inc.‘s petition of February 17, 1999, requesting that HCFC-22 and HCFC-142b, along with a third chemical, HCFC-124, also be approved as acceptable substitutes for HCFC-141b in foam applications. 65 Fed. Reg. 42,653, 42,656 (July 11, 2000). HCFC-22 and HCFC-142b were already in use in several foam applications, due to EPA‘s 1994 approval of those chemicals as CFC substitutes, 59 Fed.Reg. at 13,083, and ATOFINA‘s petition, if granted, would have permitted their use as substitutes for HCFC-141b as well. EPA issued a notice of proposed rulemaking, in which it proposed to revisit the status of HCFC-141b, HCFC-22, HCFC-124, and HCFC-142b, and to list all four as unacceptable in all foam applications, both as substitutes for CFCs and for each other. 65 Fed.Reg. at 42,656. The proposed rule, inter alia, had the effect of denying ATOFINA‘s petition to allow new users to use HCFC-22, HCFC-124 and HCFC-142b as substitutes for HCFC-141b, but also swept more broadly by effectively proposing to disallow all existing use of the four hydrochlorofluorocarbons. EPA explained that it was proposing to list the chemicals as unacceptable because they had significant ozone-depleting potential and “there are technically feasible zero-ODP [ozone-depleting-potential] substitutes available.”
EPA received numerous comments on the proposed rule, many of which focused on the economic impact, particularly to small businesses, of comprehensively delisting the four chemicals at issue; the bulk of these related to the economic hardship that existing users of HCFC-22 and HCFC-142b would face from the proposed ban. After the comment period closed, EPA obtained additional information through new comments, meetings with industry representatives, and a consultant it hired to gather additional information on the feasibility of alternatives to HCFC-141b in certain sectors. EPA‘s consultant‘s report in particular expressed
After receiving additional comment, EPA issued a final rule implementing its proposed rule in some respects but not others. 67 Fed. Reg. 47,703 (July 22, 2002). First, EPA deferred reaching a decision on whether it would permit continued use of HCFC-141b.
Anticipating based on its own market analysis that it will lose sales volume for HFC-245fa if some users are permitted to substitute HCFC-22 and HCFC-142b for HCFC-141b, Honeywell filed this petition for review. See
II.
As a threshold matter, we address EPA‘s contention that Honeywell lacks standing under Article III of the Constitution as well as prudential standing to challenge the final rule. EPA sees this lawsuit as “nothing more than a futile effort to bolster the demands for [Honeywell‘s] product, HFC-245fa, in a market that cannot use the product because of technical constraints.” Resp. Br. at 3. For Article III standing, Honeywell points to its “substantial economic injury—lost sales of HFC 245fa.” Pet. Br. at 13. For prudential standing, Honeywell points to “its role in the market for substitutes to ozone-depleting substance that Congress created in Section 612 of the CAA.”
A.
A party wishing to challenge agency action must meet the familiar Article III requirements of injury in fact, traceability, and redressability. See Lujan v. Defenders of Wildlife, 504 U.S. 555, 560-61, 112 S.Ct. 2130, 2136, 119 L.Ed.2d 351 (1992); Ethyl Corp. v. EPA, 306 F.3d 1144, 1147 (D.C.Cir.2002). The final rule authorizes the use of HCFC-22 and HCFC-142b as substitutes for HCFC-141b only pursuant to narrowed use limits, conditioned upon the user‘s ability first to ascertain and document that non-ozone-depleting alternatives, such as HFC-245fa, are not technically feasible for the specific application of HCFC-22 and HCFC-142b. EPA contends, therefore, that Honeywell suffers no “injury in fact” from having those chemicals listed as acceptable because the rule permits their use only by parties who are not potential purchasers of Honeywell‘s product.
While the narrowed use limits may very well cause Honeywell‘s injury to be smaller than it would have been if the EPA had approved ATOFINA‘s petition outright, they defeat standing only if the court can conclude that there are no additional foam manufacturers that would purchase HFC-245fa if HCFC-22 and HCFC-142b were unavailable. This assumption is not justified on the rulemaking record. The final rule,
Similarly unpersuasive, for the same reason, is EPA‘s speculation that Honeywell might suffer no injury from the rule even if it could lead to the use of HCFC-22 or HCFC-142b by customers who might otherwise purchase HFC-245fa, either because customers might all choose different approved alternatives, because customers permitted to use HCFC-22 and HCFC-142 might nonetheless opt to purchase HFC-245fa, or because Honeywell might sell enough additional HCFC-22 and HCFC-142b, both of which it also manufactures, to compensate for any lost HFC-245fa sales. The Preziotti affidavit speaks directly to this question, stating that Honeywell‘s projected revenues from increased sales of HCFC-22 and HCFC-142b, neither of which is proprietary, would not offset HFC-245fa revenues lost as a result of the rule. EPA offers no evidence to the contrary. While EPA points to Honeywell‘s comments during the rulemaking that HFC-245fa is less expensive than HCFC-142b or HCFC-22, those figures refer to overall system cost, not the cost of HFC-245fa to foam manufacturers; EPA‘s consultant‘s report indicates the cost of HFC-245fa is meaningfully higher than the cost of competing chemicals.
Honeywell satisfies the traceability requirement because the rule legalizes the entry of a product into a market in which Honeywell competes—the market for approved substitutes for HCFC-141b. EPA maintains that Honeywell cannot demonstrate that it would benefit from a decision listing HCFC-22 and HCFC-142b as unacceptable because doing so would require speculation about the purchasing decisions of third parties not before the court. There is not much to this chain-of-speculation objection; it is well established that “[p]arties suffer cognizable injury under Article III when an agency ‘lift[s] regulatory restrictions on their competitors or otherwise allow[s] increased competition.‘” Wabash Valley Power Ass‘n, Inc. v. FERC, 268 F.3d 1105, 1113 (D.C.Cir.2001) (quoting Associated Gas Distribs. v. FERC, 899 F.2d 1250, 1259 (D.C.Cir. 1990)); see also Bristol-Myers Squibb Co. v. Shalala, 91 F.3d 1493, 1499 (D.C.Cir. 1996). As a favorable opinion of the court could remove the competing chemicals from the market, redressability is satisfied as well; as discussed, removal of these competing products, even if customers us-
B.
In addition to the constitutional requirements of Article III, a petitioner seeking review of agency action must also demonstrate prudential standing to bring the suit; in other words, that “the interest it seeks to protect ‘is arguably within the zone of interests to be protected or regulated by the statute ... in question.‘” Cement Kiln Recycling Coalition v. EPA, 255 F.3d 855, 870 (D.C.Cir.2001) (per curiam) (“Cement Kiln“) (quoting Ass‘n of Data Processing Serv. Orgs. v. Camp, 397 U.S. 150, 153, 90 S.Ct. 827, 829, 25 L.Ed.2d 184 (1970)). The zone of interests test “is not meant to be especially demanding,” excluding only those whose interests are “so marginally related to or inconsistent with the purposes implicit in the statute that it cannot reasonably be assumed that Congress intended to permit the suit.” Clarke v. Sec. Indus. Ass‘n., 479 U.S. 388, 399, 107 S.Ct. 750, 756, 93 L.Ed.2d 757 (1987). Our cases have pointed out that a party need not share Congress’ motives in enacting a statute to be a suitable challenger to enforce it; “parties motivated by commercial interests routinely satisfy the zone of interests test,” as “[c]ongruence of interests, rather than identity of interests, is the benchmark.” Amgen, Inc. v. Smith, 357 F.3d 103, 108-09 (D.C.Cir.2004). If there is reason to believe that a party‘s interest in statutory enforcement will advance, rather than hinder, the operation of a statute, the court can reasonably assume that Congress intended to permit the suit.
EPA protests that Honeywell‘s interest in enforcing
PART II
SENTELLE, Circuit Judge, writing in Part II the opinion of the court:
Honeywell brings this petition for review arguing that EPA exceeded its statutory authority under Clean Air Act (“CAA“) section 612(c) by approving HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b in certain limited end uses, and therefore allowing those two chemicals to compete with Honeywell‘s approved substitute, HFC–245fa. The argument is that EPA premised its approval on the economic impact of denying ATOFINA‘s petition (which would have limited the market for substitutes to HFC-245fa). Because section 612(c), Honeywell claims, does not permit EPA to consider economic factors in the approval process, this approval exceeded EPA‘s statutory authority under the CAA.
We agree that EPA‘s rule considered economic factors and grant Honeywell‘s petition for review. We also hold that the only permissible remedy under the CAA is to vacate the rule. We therefore vacate the rule to the extent it approves ATOFINA‘s application to list new uses of HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b in certain limited end uses.
I.
HCFC-141b is a blowing agent used to manufacture certain types of foam, primarily foam insulation. The rule under review listed new uses of HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b in some foam end uses and unacceptable in others. EPA found that those two chemicals were acceptable substitutes for HCFC-141b in foam insulation used in commercial refrigeration, sandwich-panel insulation, polyurethane slabstock, and other foams, assuming users intending to use the substitutes ascertain and document that other acceptable alternatives are not “technically feasible.” Protection of Stratospheric Ozone, 67 Fed.Reg. 47,703, 47,711 (July 22, 2002).
EPA justified this conclusion by noting that use of these two substitutes in these end uses was widespread (because they are similar in cost to HCFC-141b), and that there were diverse commercial applications for such foams, each of which had unique “technical considerations.”
II.
The first issue we must decide is whether this justification for approving new uses of HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b relied on economic factors.1 EPA‘s defense to Honeywell‘s challenge is not that
The flaw in EPA‘s position is the assumption that technical constraints exclude considerations of economics. In truth, economic feasibility is part of technical feasibility. It is often possible to fit a round peg in a square hole if enough money is spent to make the round peg fit. In other words, a given change in manufacturing technique may be “technically infeasible” only as compared to some baseline of what it would cost to change the technique.
The rule confirms that the technical considerations considered by the agency intersect with economic considerations. For example, the need for refrigerated truck bodies and insulated rail cars to “maximiz[e] internal dimensions,”
EPA‘s reliance on economic constraints requires reversal of its rule. As stated, EPA does not justify the rule on the ground that
For these reasons, we grant the petition for review.
III.
The second issue we must decide is the proper remedy to correct the agency‘s error. We hold that remedy is to vacate the rule to the extent it approves ATOFINA‘s application to list new uses of HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b in certain limited end uses.
We read the judicial review provisions of the CAA to authorize us only to vacate, rather than remand, for the sort of challenge at issue here. Honeywell‘s challenge is a substantive challenge to the agency‘s statutory authority to promulgate the rule. Such challenges are governed by
Section 307(d)(9) provides that “the court may reverse any ... action found to be ... in excess of statutory jurisdiction, authority, or limitations, or short of statutory right.”
We do realize that there is circuit “precedent for the authority of the court to remand without vacating.” Milk Train, Inc. v. Veneman, 310 F.3d 747, 758 (D.C.Cir.2002) (Sentelle, J., dissenting); see also id. at 755-56 (majority opinion) (citing cases). To our knowledge, however, our only case under the CAA holding that remand, rather than vacatur, is the proper remedy is Davis County Solid Waste Management v. EPA, 108 F.3d 1454 (D.C.Cir.1997) (per curiam), which we do not think governs our holding here. In Davis, this Court held that EPA exceeded its statutory authority under the CAA, yet remanded without vacating the rule. Id. at 1459. However, in Davis we did not analyze the actual language of section 307(d)(9), and it does not appear that the parties brought that language to the court‘s attention. That decision is therefore not binding on this Court. For “[t]he Supreme Court held long ago that ‘[q]uestions which merely lurk in the record, neither brought to the attention of the court nor ruled upon, are not to be considered as having been so decided as to constitute precedents.‘” Checkosky v. SEC, 23 F.3d 452, 492 (D.C.Cir.1994) (per curiam) (separate opinion of Randolph, J.) (quoting Webster v. Fall, 266 U.S. 507, 511, 45 S.Ct. 148, 149, 69 L.Ed. 411 (1925)); see also In re Cheney, 334 F.3d 1096, 1118 n. 8 (D.C.Cir.2003) (Randolph, J., dissenting), vacated on other grounds by Cheney v. U.S. Dist. Court for the Dist. of Columbia, 542 U.S. 367, 124 S.Ct. 2576, 2592, 159 L.Ed.2d 459 (2004). We do not read court cases like we read statutes; unlike statutes, cases derive their binding force from the necessity to avoid revisiting arguments and issues litigated before and decided by those courts, not from the deductive implications of their holdings. The currency of courts is principle, not commands, and we violate no principle laid down by Davis by analyzing the actual words of the statute setting forth the extent of this Court‘s remedial power over the EPA‘s CAA rules. In light of Davis‘s silence on the interpretation of the term “reverse” in section 307(d)(9), Davis is not binding on that question.
In sum, vacatur, rather than remand, is the only remedy we are authorized to impose to correct the error in the rule under review.
IV.
For the reasons expressed above, we vacate the rule with respect to those end uses in which EPA permitted limited new use of HCFC-22 and HCFC-142b as acceptable substitutes for HCFC-141b and remand to the EPA for proceedings not inconsistent with this opinion.
RANDOLPH, Circuit Judge, concurring, with whom SENTELLE, Circuit Judge, joins:
I join the per curiam opinion and Judge Sentelle‘s opinion in part II. I write sepa-
It is easy to forget that when we vacate and remand, as we are doing here, there will be a safety valve. The agency, and any intervenors on its side, will have the opportunity to file post-decision motions demonstrating why the unlawful order or rule should remain in place during proceedings on remand. See, e.g., U.S. Tel. Ass‘n v. FCC, 188 F.3d 521, 531 (D.C.Cir.1999). Vacating an order or rule and then entertaining such stay motions has several important advantages over remanding without vacating. First, it preserves the adversary process. When we simply order a remand at the end of our merits opinion we are invariably making a remedial decision without the benefit of briefing or argument. It is quite rare for the parties even to mention the question of remedy in their merits briefs. In post-decision motions on stay applications, that will be the question they address. The court thus will have the benefit of hearing from both sides. Second, in deciding whether to allow unlawful agency action to remain in place during the remand (by way of a stay), the court will act with its eyes open and will have the information needed to assess the consequences of granting or denying a stay. Third, the existence of a stay with time limits, rather than an open-ended remand without vacatur, will give the agency an incentive to act promptly; when we simply remand, the agency has no such incentive. Fourth, there is a long-standing body of law in this circuit establishing the factors that determine whether a stay should be granted. See, e.g., Virginia Petroleum Jobbers Ass‘n v. FPC, 259 F.2d 921, 925 (D.C.Cir.1958); WMATA v. Holiday Tours, Inc., 559 F.2d 841, 843 (D.C.Cir.1977); Wisconsin Gas Co. v. FERC, 758 F.2d 669, 673-74 (D.C.Cir. 1985) (per curiam). These include the likelihood that the agency‘s position will prevail on remand; the likelihood that there will be irreparable harm without the stay; the prospect that others will be harmed if the court grants the stay; and the public interest in granting the stay. Id. Remanding without vacating is in effect granting an indefinite stay of the effectiveness of the court‘s decision. Yet we have issued many remand-only orders without mentioning or analyzing any of the considerations that should guide our remedial judgment. See, e.g., Western Resources, Inc. v. FERC, 9 F.3d 1568, 1581 (D.C.Cir.1993); Laclede Gas Co. v. FERC, 997 F.2d 936, 948 (D.C.Cir.1993); City of Mesa v. FERC, 993 F.2d 888, 898 (D.C.Cir. 1993). Even when we have offered some reasons for remanding without vacating, the reasons given are different from the factors set forth in Virginia Petroleum Jobbers, which I believe should be controlling. See, e.g., Sugar Cane Growers Coop. of Fla. v. Veneman, 289 F.3d 89, 98 (D.C.Cir.2002). I would therefore vacate and remand regardless whether a judicial review provision gave us discretion merely to remand and leave the illegal rule in place.
ROGERS, Circuit Judge, concurring in part and dissenting in part:
I concur in holding that EPA impermissibly considered costs in the rule on review. See Op. Part II. I write separately in Part I on the nature of the error, because I cannot join the court‘s reasoning, and in Part II on the appropriate remedy, because the court has ignored binding precedent. Thereafter, in light of the required remand, I address in Part III Honeywell‘s contention that EPA‘s past approval of other substitute chemicals as safe alternatives preclude it from making any exceptions authorizing use of HCFC-
I.
The challenged regulation permits new use of HCFC-22 and HCFC-142b only when “necessary to meet performance or safety requirements,” and “technical constraints [] preclude the use of other available substitutes.”
This reading of the regulation is certainly natural, as it gives the term “preclude” its most obvious meaning of “to make impossible.” AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE 212 (4th ed.2000). Indeed, absent EPA‘s reference in the final rule to costs, the court would likely read the regulation as EPA‘s counsel suggests, giving the word “preclude” its most natural, dictionary meaning. Cf. Citizens Against Burlington, Inc. v. Busey, 938 F.2d 190, 202-02 (D.C.Cir.1991). If technical constraints must “make impossible” the use of an approved substitute before use of a hydrochlorofluorocarbon is permitted, then the court‘s concern about EPA permitting HCFC-22 or HCFC-142b use on the basis of mere convenience or cost, see Op. at 547-48, would be inapposite: modifications might be required to shift to an approved substitute that “make difficult” or “make costly” or “make inconvenient” the use of an approved substitute, but they would not “preclude” it. Notably, the record before the court indicates that the transition from HCFC-141b to HCFC-22 or HCFC-142b is more likely to involve equipment modifications than the transition from HCFC-141b to an approved alternative. HFC-245fa, Honeywell‘s product, is a liquid agent like HCFC-141b, and was developed specifically as a “drop-in” substitute for use in the same equipment. HCFC-22 and HCFC-142b, on the other hand, are both gaseous agents, which, EPA acknowledged, would often require modifications to equipment currently using liquid agents such as HCFC-141b. See 67 Fed.Reg. 47,703, 47,713-14 (July 22, 2002). Some transition costs, then, would cut against HCFC-22 and HCFC-142b rather than in their favor. Thus, EPA counsel‘s suggestion, that the HCFCs’ use under the new regulation is intended for cases where foam made with an approved substitute would not be functional, is not without plausibility.
Under a natural reading of the language used by EPA, HCFC-22 and HCFC-142b use would be reserved, not for situations where it would be “possible to fit a round peg in a square hole” with sufficient expense, Op. at 547, but for situations where the physical limitations of approved foam-blowing (or foam-pouring) agents are such that equipment or design modifications will not be sufficient to meet “performance or safety requirements.” With this view of EPA‘s meaning, the fact that EPA also referred to costs in explaining the regulation would be harmless error. Cf. PDK Laboratories Inc. v. DEA, 362 F.3d 786, 799 (D.C.Cir.2004);
The court appears to hold that EPA impermissibly considered costs at two stages of its decision: first, by comparing the functionality of foam made with approved alternatives with foam made with HCFC-22 and HCFC-142b, and second, by considering the costs manufacturers would incur in switching to approved alternatives. See Op. at 547-48. While EPA relied on the first consideration, it was not error to do so. The court defines too broadly what it means for EPA to impermissibly consider costs. Expressing concern over whether a substitute product actually works (or works as well) as the substance it is replacing is, of course, a decision that may carry economic consequences, as where a less functional foam product will be less commercially desirable. If a foam is denser, picnic coolers will have to be heavier to keep the same amount of food cold; if a foam is less insular, it will require thicker walls in refrigerators or houses that use it as insulation. But that does not convert every decision EPA makes about whether a substitute works into a decision about costs: were that so, every approval or disapproval decision EPA makes under the SNAP program would be suspect, an extreme position Honeywell does not urge.
The court‘s second theory, however—that EPA based its decision in part on the costs manufacturers would incur in switching to approved alternatives—is indicated by the record. See Op. at 547-48. A statement by EPA in the rule, about protecting small businesses, calls into question the natural reading of the regulation urged by EPA counsel:
In other cases, where HCFC-141b is used in niche applications, EPA believes foam manufacturers may experience difficulties and delays in transitioning from HCFC-141b to non-ozone-depleting alternatives. Given the constraints associated with cost and timing of transitioning to alternatives for small businesses, and the need to facilitate a smooth and equitable transition from HCFC-141b, EPA believes ... it is appropriate to approve use of HCFC-22 and/or HCFC-142b as substitutes for HCFC-141b ... provided that the users ... ascertain and document that other acceptable alternatives are not technically feasible.
67 Fed.Reg. at 47,714 (emphasis added). It is difficult to understand this passage unless EPA believes there is some subset of end-users for whom it would be possible yet very costly to switch to non-ozone-depleting alternatives, and that the rule grants this subset some form of relief. This, in turn, suggests that EPA construes the term “preclude” to mean something less than “make impossible,” such as to “make difficult” or “make cumbersome.”1
Section 612(c) directs the Administrator of EPA to make the use of environmentally harmful substitutes unlawful if, inter alia, alternatives presenting reduced harm are “currently or potentially available“; the regulations provide that a substitute will be deemed “unacceptable” if “other alternatives exist that reduce overall risk.”
For present purposes, as the court states, see Op. at [1365-66], there is no need to decide whether EPA could, consistent with the text and purpose of
Whether
II.
While the court properly identifies error in the regulation on review, it goes astray on the appropriate remedy. Under the court‘s precedent, the proper remedy in this case is remand, not vacatur. The court explained in Allied-Signal v. U.S. Nuclear Regulatory Comm‘n, 988 F.2d 146, 150-51 (D.C.Cir.1993), that remand is preferable to vacatur when an agency might be able to support a rule through further explanation and the “consequences of vacating may be quite disruptive.” Id. at 151. See also Sinclair v. FCC, 284 F.3d 148, 162 (D.C.Cir.2002); Fox Television Stations, Inc. v. FCC, 280 F.3d 1027, 1047-49 & 1052-53 (D.C.Cir.2002). The two Allied-Signal factors are both implicated here.
First, the identified defect in the rule that the court has identified may be curable. As discussed, the final regulation permits new use of HCFC-22 and HCFC-142b in certain end-uses when “necessary to meet performance or safety requirements,” and “technical constraints [] preclude the use of other available substitutes.”
Second, were the court to vacate the final rule with respect to the end-uses in which EPA has permitted limited new HCFC-22 and HCFC-142b use, the result would likely be that all uses of HCFC-22 and HCFC-142b within those end-uses would become permissible, as more than 90 days have elapsed since ATOFINA‘s petition and the chemicals were not listed as unacceptable in those end-uses prior to the proposed rule. See
Rather than engage the prudential inquiry our case law requires to determine whether remand or vacatur is the proper course of action, the court sua sponte holds that there is no statutory authority for the court to remand without vacating. See Op. at 548-49. It brushes aside our exhaustive caselaw on this question, much of it quite recent, see, e.g., Milk Train, Inc. v. Veneman, 310 F.3d 747, 755-56 (D.C.Cir.2002); Fox Television Stations, 280 F.3d at 1047-49 & 1052-53; County of Los Angeles v. Shalala, 192 F.3d 1005, 1023 (D.C.Cir.1999); Radio-Television News Dirs. Ass‘n v. FCC, 184 F.3d 872, 887-89 (D.C.Cir.1999); Allied-Signal, 988 F.2d at 150-51, by claiming that these cases do not actually constitute precedent and are, in any event, distinguishable. See Op. at 549. Neither argument is persuasive.
The court rewrites the law of precedent, allowing a later court to avoid binding decisions it prefers not to follow if the earlier decisions did not fully state their reasoning. See Op. at 549. But it is long established that irrespective of whether a later court may conclude that its view is the better view, it is bound, absent en banc review, by the court‘s prior decisions. See LaShawn A. v. Barry, 87 F.3d 1389, 1395 (D.C.Cir.1996) (en banc);
Nor can the court reasonably distinguish our precedent by pointing out that most of it arose under the Administrative Procedure Act (“APA“) rather than the CAA, and that the CAA only grants the court the power to “reverse” administrative actions.
III.
Finally, in light of the required remand, I address Honeywell‘s contention that it is entitled to greater relief than the court grants. As discussed, EPA‘s decision to approve some limited use of HCFC-22 and HCFC-142b was based in large part on its concern that it lacked sufficient information on whether existing “safe alternatives” for HCFC-141b could always function adequately as substitutes. Honeywell contends that this inquiry was foreclosed by EPA‘s past approval of safe alternatives to HCFC-141b and past refusal to approve ozone-depleting substances as safe alternatives, and that EPA was thus precluded from approving any ozone-depleting substances as substitutes for HCFC-141b, in any end-uses. However, irrespective of whether
Under
In Honeywell‘s view, EPA‘s approval in 1999 of HFC-245fa in “all foam end-uses,” 64 Fed.Reg. 68,039, 68,041 (Dec. 6, 1999), as well EPA‘s approval of other non-ozone-depleting substitutes, see 67 Fed.Reg. at 47,711, Table B, encompassed a determination that it is “technically feasible” to use HFC-245fa in all foam end-uses, and that it is therefore “currently or potentially available.” This contention conflates two terms in
Honeywell‘s related contention that EPA impermissibly deviated from its stated policy of never approving one ozone-depleting substance as a substitute for another fails for essentially the same reason. In prior rules where EPA had expressed this position, such as in its 1999 refusal to list NARM-22, a blend containing HCFC-22, EPA had always qualified it by noting that “[o]ther alternatives ... are already acceptable that do not contain any ozone-depleting refrigerants.” 64 Fed.Reg. 22,982, 22,984 (Apr. 28, 1999). Similarly, in 1993, EPA stated that it “views HCFCs as important interim substitutes that will allow for the earliest possible phaseout of CFCs and other Class I substances” and “believes that the use of HCFCs should be limited to only those applications where other environmentally acceptable alternatives do not exist.” 58 Fed.Reg. at 65,026. The informal expressions of EPA policy at recent trade shows, to which Honeywell refers, similarly contain the qualification that EPA is “unlikely” to approve any HCFCs as substitutes for HCFC-141b because, among other things, there are “non-ozone depleters available.” All these amount to are a series of situations where EPA found non-ozone-depleting “safe al-
Honeywell can fare no better with its other contentions, although I do not reach the merits of either. The relief granted by the court eliminates the need to address Honeywell‘s contention that it did not have adequate notice of EPA final decision. And Honeywell‘s contention that the final rule‘s delegation of technical feasibility determinations to the end-user is contrary to
